833 research outputs found
Supplemental Material, Appendix_IPSSInvestigators_20032014_final - Characteristics and Outcome in Children With Craniectomy Following Acute Ischemic Stroke in the International Pediatric Stroke Study
No full textSupplemental Material, Appendix_IPSSInvestigators_20032014_final for Characteristics and Outcome in Children With Craniectomy Following Acute Ischemic Stroke in the International Pediatric Stroke Study by Laura L. Lehman, Gabrielle DeVeber, Paola Pergami, Kristin P. Guilliams, Melissa Chung, Ryan Felling, Michael M. Dowling, Michael J. Rivkin and on behalf of the International Pediatric Stroke Study Investigators in Journal of Child Neurology</p
Supplementary table -Supplemental material for Children with post-stroke epilepsy have poorer outcomes one year after stroke
No full textSupplemental material, Supplementary table for Children with post-stroke epilepsy have poorer outcomes one year after stroke by Christine K Fox, Lori C Jordan, Lauren A Beslow, Jennifer Armstrong, Mark T Mackay, Gabrielle deVeber and on behalf of the SIPS Investigators in International Journal of Stroke</p
Gabrielle Calvocoressi, 44th Annual ODU Literary Festival
No full textGabrielle Calvocoressi is the author of The Last Time I Saw Amelia Earhart; Apocalyptic Swing, which was a finalist for the LA Times Book Prize; and Rocket Fantastic, winner of the Audre Lorde Award for Lesbian Poetry. Calvocoressi has received numerous awards and fellowships including a Stegner Fellowship and Jones Lectureship from Stanford University, a Rona Jaffe Woman Writer’s Award, a Lannan Foundation residency, the Bernard F. Conners Prize from The Paris Review, and a residency from the Civitella Ranieri Foundation. Calvocoressi teaches at UNC Chapel Hill and lives in Durham, North Carolina
Abstract WMP105: Quantitative Assessment of Cerebrovascular Reactivity in Paediatric Moyamoya
No full textOutcome after stroke in childhood
No full textThe field of stroke and cerebrovascular disease in children is one in which there has been much recent research activity, leading to new clinical perspectives. This book for the first time summarises the ?state of the art? in this field. A team of eminent clinicians, neurologists and researchers provide an up-to-the-minute account of all aspects of stroke and cerebrovascular disease in children, ranging from a historical perspective to future directions, through epidemiology, the latest neuroimaging techniques, neurodevelopment, co-morbidities, diagnosis and treatment. The authors? practical approach to the clinical problems makes this essential reading for practising clinicians. It will also be of interest to researchers in the field
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
No full textThis chapter about antithrombotic therapy in neonates and children is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs, and Grade 2 suggests that individual patient values may lead to different choices (for a full understanding of the grading, see Guyatt et al in this supplement, pages 123S-131S). In this chapter, many recommendations are based on extrapolation of adult data, and the reader is referred to the appropriate chapters relating to guidelines for adult populations. Within this chapter, the majority of recommendations are separate for neonates and children, reflecting the significant differences in epidemiology of thrombosis and safety and efficacy of therapy in these two populations. Among the key recommendations in this chapter are the following: In children with first episode of venous thromboembolism (VTE), we recommend anticoagulant therapy with either unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) [Grade 1B]. Dosing of IV UFH should prolong the activated partial thromboplastin time (aPTT) to a range that corresponds to an anti-factor Xa assay (anti-FXa) level of 0.35 to 0.7 U/mL, whereas LMWH should achieve an anti-FXa level of 0.5 to 1.0 U/mL 4 h after an injection for twice-daily dosing. In neonates with first VTE, we suggest either anticoagulation or supportive care with radiologic monitoring and subsequent anticoagulation if extension of the thrombosis occurs during supportive care (Grade 2C). We recommend against the use of routine systemic thromboprophylaxis for children with central venous lines (Grade 1B). For children with cerebral sinovenous thrombosis (CSVT) without significant intracranial hemorrhage (ICH), we recommend anticoagulation initially with UFH, or LMWH and subsequently with LMWH or vitamin K antagonists (VKAs) for a minimum of 3 months (Grade 1B). For children with non-sickle-cell disease-related acute arterial ischemic stroke (AIS), we recommend UFH or LMWH or aspirin (1 to 5 mg/kg/d) as initial therapy until dissection and embolic causes have been excluded (Grade 1B). For neonates with a first AIS, in the absence of a documented ongoing cardioembolic source, we recommend against anticoagulation or aspirin therapy (Grade 1B)
Ep. #055 - Gabrielle Hecht
No full textThis recording and transcript form part of a collection of podcasts conducted by the Cultures of Energy at Rice University. Cultures of Energy brings writers, artists and scholars together to talk, think and feel their way into the Anthropocene. We cover serious issues like climate change, species extinction and energy transition. But we also try to confront seemingly huge and insurmountable problems with insight, creativity and laughter.In a fittingly bizarre intro for these political times, Cymene and Dominic share weird fantasies and actual plans for resistance. We then (11:57) welcome to the podcast renowned historian and ethnographer of nuclear energy, Gabrielle Hecht from the University of Michigan, author of Being Nuclear and The Radiance of France (MIT Press). Gabrielle tells us why she first became interested in nuclear power growing up in Reagan’s Cold War. We compare fears of nuclear war then and now and explore different historical constructions of “the nuclear” more generally. We talk about her concept of “toxic infrastructure” and how it can apply to places like Flint, Michigan. Gabrielle then explains how France became the country in the world most reliant upon nuclear energy for its electricity and why the French nuclear industry is in now in such a state of panic. We talk about why nuclear energy hasn’t lost its utopianism—including as a climate change fix—but why we think the nuclear solution to global warming is a red herring. We turn to Fukushima and Gabrielle reminds us that it’s also important to pay attention to the less spectacular but more common environmental and human impacts of using nuclear fuel, including the fate of people who clean reactors under normal and catastrophic conditions. We discuss uranium mining in Africa and the struggles miners have fought to have their “biological citizenship” recognized by their governments. That leads us to talk about the real costs of nuclear energy. And we close on Gabrielle’s latest work on toxicity and what she calls the African Anthropocene. Hang in there, everyone, be kind to yourselves and stay strong for the long run of resistance
- …
